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466a Tuesday, March 8, 2011of Ca2þ, dissociation of CaM from C28 occurs by a pathway in which Trp
1093, although deeply embedded in a pocket in the C-terminal lobe of
CaM, leaves first. The dissociation begins by relatively rapid release of Trp
1093, followed by very slow release of Phe 1110, removal of C28 and return
of CaM to its conformation in the free state. The intermediate of dissociation
with exposed Trp 1093 has a long lifetime (minutes), and is an activated form
of PMCA. This mechanism may explain some unique biological properties of
PMCA4b.
2522-Pos Board B508
Oligomeric Interactions of Sarcolipin and SERCA Detected by FRET
Microscopy
Joseph M. Autry, John E. Rubin, Seth L. Robia, David D. Thomas.
We have monitored molecular interactions of sarcolipin (SLN) and the sarco-
plasmic reticulum Ca- ATPase (SERCA) by measuring Fo¨rster resonance en-
ergy transfer (FRET) between fusion proteins labeled with cyan fluorescent
protein (donor) and yellow fluorescent protein (acceptor). SLN is a key mem-
brane protein that controls muscle contractility by regulating the calcium
transport activity of SERCA, and perhaps by also acting as an ATP-
activated anion channel (Becucci et al., Biophys. J. 2007, 2009). Here we
used baculovirus expression of fluorescent fusion proteins in insect cells
and FRET microscopy to provide novel evidence for (a) independent oligo-
merization of SLN and (b) regulatory complex formation between SERCA
and SLN. FRET assays demonstrated that SLN monomers self-assemble
into dimers and higher-order oligomers in the absence of SERCA, but that
SLN monomers also bind to SERCA in a 1:1 binary complex when the two
proteins are co-expressed. FRET assays further demonstrated that the binding
affinity of SLN:SLN homo-oligomers is greater than the binding affinity of
SERCA:SLN hetero-dimers, indicating that SLN monomers favor self-
association over SERCA binding. Mutating SLN residue isoleucine-17 to al-
anine (I17A) decreased FRET for SLN self-association and eliminated multi-
meric assembly of SLN, converting higher-order oligomers into monomers
and dimers. The I17A mutation also decreased FRET for SERCA:SLN
binding but maintained 1:1 stoichiometry of hetero-dimer formation. Thus,
isoleucine-17 is a residue that plays dual roles in (a) determining the distribu-
tion of SLN homo-oligomers and (b) stabilizing the formation of
SERCA:SLN hetero-dimers. When expressed in bacterial cells, wild-type
SLN prevented colony formation but the I17A-SLN mutant did not, indicating
that higher-order oligomers of SLN exhibit antibacterial activity, possibly
through channel formation. We propose that SLN exists as multiple molecular
species in muscle membranes, including SERCA-free (monomer, dimer, olig-
omer) and SERCA-bound (hetero-dimer).
2523-Pos Board B509
Identification of Phospholemman Residues Critical to Phospholemman
Oligomerization and Na Pump Association
Julie Bossuyt, Joseph C. Li, Mounir Khafaga, Linda L. Lee,
Luiza Mamikonian, Sanda Despa, Donald M. Bers.
Phospholemman (PLM or FXYD1) associates with and modulates Na pump
(NKA) function in a manner similar to phospholamban (PLB) regulation of
SERCA. That is, PLM inhibits NKA by reducing its [Na]i-affinity and PLM
phosphorylation relieves this inhibition. We have also shown that PLM forms
homo-oligomers (as does PLB) but it is unknown how PLM-PLM interactions
occur or what functional role PLM oligomers have. Here we use site-directed
mutagenesis and FRET to identify which PLM residues are critical to the
PLM-NKA and PLM-PLM association, respectively. We hypothesize that mu-
tations affecting PLM-PLM affinity will enhance PLM-NKA complexes and
display stronger NKA inhibition, and vice versa. Based on crystal NKA-
FXYD structure, the PLM sites G20, F28 & G31 were selected as potential
NKA interaction sites and I26, I29, L30, L33&L36 as putative PLM interac-
tion sites (analogous to leucine zippers thought to mediate PLB pentameriza-
tion). Alanine substitution of F28 eliminated PLM-NKA FRET (Fdonor
increase by only 0.254% vs 1852% for WT). Despite only minor effects
on PLM-NKA interaction for G31A (Fdonor increase by 1451%), its PLM-
PLM FRET was significantly increased (Fdonor increase by 5553% vs
3755% for WT). Alanine substitution of I26, L30 & L33 all significantly re-
duced PLM-PLM FRET (Fdonor increase by 1552%, 1353% and 2053% re-
spectively vs 3755% for WT) and opposing effects on PLM-NKA FRET
were observed (e.g. Fdonor increases by 3356% for L33A vs 1852% for
WT). We conclude that PLM homo-oligomers have a structural basis that par-
allels PLB (Leucine zipper). Moreover our hypothesis that altering the PLM
affinity for NKA also changes the interaction of PLM with other PLM mole-
cules (and vice versa) seems to be correct. Our data support the existence of
a dynamic equilibrium of PLM oligomers and PLM-NKA that exerts func-
tional regulation of NKA.2524-Pos Board B510
Highly Specific, Conformationally-Dependent Cross-Linking of Lys27 of
PLB to SERCA2a in Cardiac SR Vesicles from Humans
Brandy L. Akin, Larry R. Jones.
Phospholamban (PLB) inhibits SERCA2a, the Ca2þ-ATPase of cardiac sarco-
plasmic reticulum (SR), by decreasing the apparent Ca2þ affinity of the en-
zyme. The mechanism of Ca2þ pump inhibition by PLB has been studied by
our group using chemical cross-linking agents, which enable PLB-binding in-
teractions with SERCA2a to be measured simultaneously with enzyme inhibi-
tion. Previously, cross-linking of canine PLB to SERCA2a was only attainable
with Cys-scanning point mutants of PLB. For example, N27C of canine PLB
cross-links exclusively to Lys328 of canine SERCA2a with heterobifunctional
thiol-to-amine cross-linking agents after co-expression of the two proteins in
Sf21 insect cells. Here, we show with SR vesicles prepared from human hearts,
that PLB and SERCA2a are cross-linkable using DSG (disuccinimidyl gluta-
rate), a 7.7 A˚ long, homobifunctional, amine-specific cross-linking agent.
Cross-linking of human PLB to SERCA2a takes advantage of the unique Lys
residue at position 27 of human PLB, making it susceptible to amine-specific
cross-linkers without the need for mutagenesis. This was confirmed by testing
SR vesicles prepared from both human and canine ventricles; DSG cross-linked
human, but not canine, PLB to SERCA2a. Cross-linking of human PLB to
SERCA2a was completely inhibited by either Ca2þ (Ki = 0.50 mM), or the
Ca2þ pump inhibitor thapsigargin, but substantially augmented by ATP.
This is the first demonstration that PLB binds exclusively to the E2 conforma-
tion of SERCA2a in SR vesicles, preferentially the state with bound nucleotide
(E2$ATP), and not the state stabilized by thapsigargin (protonated E2). Impor-
tantly, similar results were obtained with SR vesicles prepared from both nor-
mal and failed human hearts, indicating that PLB-binding interactions with
SERCA2a are unchanged in failing myocardium. Studies are in progress to
demonstrate with human SR vesicles that Lys27 of PLB cross-links exclusively
to Lys328 of SERCA2a.
2525-Pos Board B511
Characterizing the Phospholamban-SERCA Complex by Pulsed EPR
Spectroscopy
Zachary M. James, Kurt D. Torgersen, Christine B. Karim,
David D. Thomas.
Muscle contraction and relaxation are controlled through the release and reup-
take of Ca2þ stored in the sarcoplasmic reticulum (SR). Relaxation is mediated
by the SR Ca2þ ATPase (SERCA), a pump that drives Ca2þ against its concen-
tration gradient while hydrolyzing ATP. Cardiac SERCA is regulated by phos-
pholamban (PLB), a small membrane protein that inhibits the pump except
when phosphorylated at Ser16. PLB phosphorylation restores SERCA activity
without dissociating the two proteins, instead inducing a structural change
within the PLB-SERCA complex. Although a number of studies have investi-
gated the interaction of these proteins, the relationship between phosphoryla-
tion, structure, and activity remains unresolved. We have used dipolar
electron-electron resonance (DEER) spectroscopy, a technique capable of mea-
suring distances from 2-7nm, to characterize large conformational changes
within PLB upon phosphorylation and SERCA binding. Our results show
that the transmembrane and cytoplasmic helices of PLB draw closer upon
SERCA binding, with subsequent phosphorylation compacting the structure
still further. However, relative distances between the cytoplasmic domains of
PLB and SERCA remain largely constant before and after phosphorylation,
suggesting that the observed structural change occurs in the transmembrane do-
main of PLB. Ultimately, our goal is to make exhaustive distance measure-
ments within the SERCA-PLB complex in order to understand the structural
basis of phosphorylation-mediated inhibition relief.
2526-Pos Board B512
StructuralDynamics ofSERCAandPhospholambanbyTR-FRETandTIRF
Ji Li, Christine Karim, David D. Thomas.
We used fluorescence to investigate the structure and dynamics of phospholam-
ban (PLB) and its inhibited target, sarcoplasmic reticulum Ca-ATPase
(SERCA). Time-resolved fluorescence energy transfer (TR-FRET) was used
to study the oligomeric interaction between PLB and SERCA. Previous work
on our lab has shown that PLB is primarily pentameric but SERCA binds pref-
erentially to the monomeric form in lipid vesicles. Recent EM studies suggest
that the PLB pentamer might also bind to SERCA.We tested this hypothesis by
labeling SERCA at C674 with a fluorescent donor (TMRIA) and labeling PLB
at K3 with a non-fluorescent acceptor (MGITC), then reconstituting the pro-
teins into lipid vesicles and performing TR-FRET as a function of the fraction
of acceptor-labeled PLB (xA), keeping the total PLB/SERCA molar ratio con-
stant at 10. Simulations showed that if a PLB monomer binds to SERCA, the
dependence of FRET on xA should be linear, but the binding of a PLB oligomer
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ear, and was indistinguishable from control experiments using a monomeric
mutant of PLB. We conclude that PLB binds to SERCA only as a monomer.
We used polarized TIRF to study the structure of PLB in the presence and ab-
sence of SERCA in a supported lipid bilayer. Polarized TIRF data shows that
the cytoplasmic helix of PLB, labeled with bifunctional rhodamine, is close
to be parallel to the membrane surface. SERCA binding lifts the cytoplasmic
helix away from the membrane surface. These results have important implica-
tions for the design of PLB mutants to be used in gene therapy for heart failure.
2527-Pos Board B513
Probing the Molecular Mechanism of SERCA-PLB Regulation by Time-
Resolved FRET
Elizabeth L. Lockamy, Razvan L. Cornea, Christine B. Karim,
David D. Thomas.
We are using solid-phase peptide synthesis, membrane reconstitution, an
enzyme-coupled Ca-ATPase activity assay, and time-resolved fluorescence res-
onance energy transfer (TR-FRET) to investigate the molecular mechanism by
which the cardiac Ca-ATPase (SERCA) is regulated by phospholamban (PLB).
In human heart failure, SERCA activity is inadequate, and current therapeutic
research focuses on the goal of increasing SERCA activity by reducing PLB
inhibition of SERCA. PLB inhibition is relieved by [Ca2þ] > mM or by phos-
phorylation of S16 by PKA. It has been proposed that relief of this inhibition
requires dissociation of the SERCA-PLB complex. To test this hypothesis,
we have designed and synthesized monomeric PLB variants with a FRET ac-
ceptor (DABCYL), with and without phosphorylation at S16, and then recon-
stituted them with SERCA labeled with a FRET donor (IAEDANS). After
reconstitution, the interactions of these PLB variants with SERCA were char-
acterized both functionally (Ca-ATPase activity) and physically (TR-FRET), as
affected by Ca2þ and PLB phosphorylation. We found that Ca2þ completely
relieves SERCA inhibition, while phosphorylation partially relieves SERCA
inhibition. We also found that Ca2þ and phosphorylation have slight effects
on FRET. Time resolution provided independent measurements of protein as-
sociation and structure. We conclude that inhibition of SERCA is relieved by
structural rearrangement within the SERCA-PLB complex, without dissocia-
tion of PLB from SERCA.
2528-Pos Board B514
FRETDetected Interactions of CardiacMembrane Proteins in Living Cells
Suzanne M. Haydon, Deborah Winters, Joseph Michael Autry,
Seth L. Robia, David D. Thomas.
We have investigated the structure of phospholamban (PLB) and its regulation
of the sarcoplasmic reticulum Ca-ATPase (SERCA) using fluorescence reso-
nance energy transfer (FRET) on fluorescent fusion proteins expressed in living
cells. Fusion proteins were created with either a donor fluorophore (cyan fluo-
rescent protein, CFP), or an acceptor fluorophore (yellow fluorescent protein,
YFP), attached to one terminus of the protein of interest. Both N-terminal
and C-terminal fusions of CFP and YFP were made to SERCA and N-terminal
fusions were made to PLB. These proteins were expressed and co-expressed in
HEK-293 cells, preserving normal physiological function of both proteins. The
interaction between SERCA and PLB before and after phosphorylation of PLB
was observed by FRET in cells stimulated with forskolin or isoproterenol.
Western blots of cell homogenates showed a significant increase in PLB phos-
phorylation after ten minutes of exposure to either forskolin or isoproterenol.
However, FRET measured by the recovery of CFP fluorescence after photo-
bleaching of YFP did not show large changes in binding between SERCA
and PLB that would indicate dissociation of these proteins due to PLB phos-
phorylation. Measurements made by 3-cube FRET throughout the course of
cell stimulation also indicate that there is no dissociation of the SERCA-PLB
complex upon phosphorylation. These results are consistent with in vitro
data from our lab that show a structural rearrangement in the SERCA-PLB
complex after PLB phosphorylation, rather than dissociation. Time-resolved
FRET experiments are underway to determine whether the source of small
FRET changes seen in the live cells are due to a structural rearrangement in
the SERCA-PLB complex or a change in binding for a fraction of the proteins.
2529-Pos Board B515
Conformational Dynamics of Sarcoendoplasmic Reticulum Ca-ATPase
(SERCA) Quantified by Intramolecular FRET Fluctuations
Sandeep Pallikkuth, Zhihong Hu, Seth L. Robia.
To quantify the dynamic transitions of SERCA between various structural sub-
states, we measured intramolecular FRET between fluorescent proteins fused to
the N and A domains with fluorescence lifetime fluctuation analysis. This ‘2-
color’ SERCA was subjected to pulsed laser excitation and fluorescence was
detected with time correlated single photon counting. The arrival times of pho-tons from short fluorescence bursts were
analyzed using maximum likelihood esti-
mation for determination of the donor
fluorescence lifetimes. By monitoring life-
times of a few molecules at a time, we de-
tected multiple discrete FRET levels
indicating different conformational states.
A broad range of conformations was ob-
served, including structures not detected
by steady state experiments. We also re-
corded lifetime trajectories indicating
changes in FRET efficiency consistent with rapid transitions between long-
lived conformational states. The data provide insight into SERCA structural dy-
namics during the Ca transport cycle.
2530-Pos Board B516
Identifying Calcium ion Access Points and Transport Pathways in SERCA
Maria Musgaard, Lea Thøgersen, Birgit Schiøtt, Emad Tajkhorshid.
The sarco(endo)plasmic reticulum calcium ATPase (SERCA) is one of the best
structurally characterized membrane transporters with numerous high resolu-
tion crystal structures available for several different functional states. These
structures have clearly established the involvement of large conformational
changes in transporting Ca2þ ions across the sarcoplasmic reticulummembrane
against the concentration gradient, harvesting the required energy from ATP-
hydrolysis. Unfortunately, it still has not been possible to crystallize SERCA
(or any other P-type ATPase) in a conformation with an open cytoplasmic path-
way leading to the two Ca2þ binding sites located in the middle of the trans-
membrane domain, halfway across the bilayer. Different Ca2þ entry points
have been suggested, however, how Ca2þ reach the binding sites is yet to be
learned.
We have studied different functional states of SERCA embedded in a lipid bi-
layer and surrounded by water molecules and potassium chloride with exten-
sive all-atom molecular dynamics simulations. Simulations of Ca2þ-free
states demonstrate how positive ions are attracted to the cytoplasmic surface
of the transmembrane domain at a region close to the kinked part of transmem-
brane helix 1 (TM1). The kinked part is rich in acidic residues. Ion densities
show that potassium ions accumulate in this region, and electrostatic potential
maps calculated for the protein likewise identifies a negative potential here.
Simulations of Ca2þ-bound states, with occluded Ca2þ binding sites, illustrates
water molecules actually finding their way into the ion binding site nearest the
cytoplasmic surface. This water pathway begins from the region close to the
TM1-kink seen to attract positive charge in Ca2þ-free states.
On this basis, we suggest that at least one Ca2þ ion, and probably both, access
the Ca2þ ion binding sites through a pathway starting close the TM1-kink,
which with several acidic residues contributes to the attraction of ions.
2531-Pos Board B517
Conformational Changes of SERCA Revealed by Intramolecular FRET
Zhanjia Hou, Zhihong Hu, Sandeep Pallikkuth, Daniel Blackwell,
Seth L. Robia.
The first structures of the sarcoendoplasmic reticulum ATPase (SERCA) deter-
mined by X-ray crystallography suggested that pump undergoes a large confor-
mational change during catalytic cycling. The transition from the E1 (Ca-
bound) state to the E2 (Ca-free) state was predicted to decrease inter-domain
separation distance with closure of the SERCA cytoplasmic headpiece. To
test this model, we fused Cerulean to the A-domain and YFP to the N or P
or TM-domain of SERCA2a. These ‘‘2-color’’ SERCA constructs were ex-
pressed in AAV cells, and SERCA structure transitions were detected by
changes in intramolecular fluorescence resonance energy transfer (FRET).
FRET decreased with thapsigargin for the two N-domain fusion sites (residues
510, 577), while the P- (residue 610) and TM- domain (C-terminus) fusions
showed increased FRET with thapsigargin. Unexpectedly, FRET in permeabi-
lized cells was higher in Ca [10 mM] than in EGTA for all constructs, suggest-
ing an increase in domain separation distance with the E1 to E2 transition.
These observations were supported by parallel experiments in fluorescence life-
time distribution (FLD) analysis. FLD resolved two broad distributions of fluo-
rescence lifetimes for 2-color SERCA expressed in live cardiac myocytes,
consistent with two major FRET states. The relative populations of these states
oscillated with electrical pacing, favoring the high FRET (short distance) state
during systole (contraction) and the low FRET (long distance) state during
diastole (relaxation). We expect 2-color SERCA constructs to be useful for ex-
ploring the magnitude, direction, and kinetics of calcium pump conformational
changes. They may also be useful for screening candidate compounds for mod-
ulation of SERCA pump structure and function.
